News

August 3, 2020

Avia Pharma continues to expand – acquires Pharmaprim

The pharmaceutical company Avia Pharma has acquired the Swedish pharmaceutical company Pharmaprim, with a product portfolio consisting of drugs in...
Read More
January 1, 2020

Avia Pharma acquires two skin products from Perrigo

On December 31, 2019, Avia Pharma acquired the rights to ACO Karbamid and ACO Glycerol from Perrigo. -We are particularly...
Read More
June 7, 2019

Avia Pharma signs licence agreement for Viiral

Following a strong sales increase in the current portfolio, Viiral AS have trusted Avia Pharma to launch Viiral on the...
Read More
January 5, 2019

Avia Pharma signs license agreement for Femarelle

With a strong foot print in women’s health Avia Pharma are trusted to launch Femarelle in Finland. “We are proud...
Read More
February 5, 2018

Long term license agreement signed for Intrarosa®

Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®. Intrarosa® is locally...
Read More
February 1, 2018

Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology

Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology. Mattias Wik has 20 years of experience from the pharmaceutical...
Read More
January 15, 2018

Parents prepared to pay out of pocket for vitamin D without palm oil

Currently there are two Vitamin D drops being sold on the Swedish market. ACO Vitamin D drops does not contain...
Read More
December 20, 2017

License agreement signed for Vectavir, Vectatone and Silence

Following a very strong sales increase for all products, Omega Pharma and Avia Pharma has decided to expand their co-operation....
Read More
December 15, 2017

Avia Pharma appoints Marie Wikman as Business Unit Director OTC

Avia Pharma appoints Marie Wikman as Business Unit Director OTC. Marie Wikman has been working her whole career building strong...
Read More
November 30, 2017

Long term license agreement signed for Spasmex and Vagitin

Avia Pharma and Dr Pfleger have entered into a long-term license agreement for Spasmex (Trospium) and Vagitin (Nystatin). The license...
Read More